Memphis Pharmaceuticals (MPCI)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Insider Trades
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

{{ 'components.chart.period.' + period | translate }}

{{ 'components.chart.type.' + type | translate }}

This mark means that there are news on this date.

Stock

Par Value 10.0 Egyptian Pound

Market Cap 3,435,250,000.00 Egyptian Pound

Book Value (BVPS) 26.13 Egyptian Pound Based on: First Quarter 2026

P/B Ratio 4.46 Last update: 2025-12-19

EPS 26.89 Egyptian Pound Based on: First Quarter 2026

P/E Ratio 6.80 Last update: 2025-12-19

Trading Currency Egyptian Pound

Company Statistics

News

Memphis Pharmaceutical’s shareholders approve company’s continuity Management Decisions

Memphis Pharmaceutical’s board approves capital raise Board of Directors

Memphis Pharmaceutical approves financing to pay off EGP 300m debt Board of Directors

Memphis Pharmaceutical’s annual profits climb 77% Financial Results

Memphis Pharmaceutical targets EGP 50m profits in FY22/23 Financial Results

Memphis Pharmaceutical to obtain financing from ADIB Companies Investments

Market Announcements